149 related articles for article (PubMed ID: 20511541)
1. Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo.
Na IK; Markley JC; Tsai JJ; Yim NL; Beattie BJ; Klose AD; Holland AM; Ghosh A; Rao UK; Stephan MT; Serganova I; Santos EB; Brentjens RJ; Blasberg RG; Sadelain M; van den Brink MR
Blood; 2010 Sep; 116(11):e18-25. PubMed ID: 20511541
[TBL] [Abstract][Full Text] [Related]
2. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG
J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148
[TBL] [Abstract][Full Text] [Related]
3. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
[TBL] [Abstract][Full Text] [Related]
4. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
5. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo.
Ponomarev V; Doubrovin M; Lyddane C; Beresten T; Balatoni J; Bornman W; Finn R; Akhurst T; Larson S; Blasberg R; Sadelain M; Tjuvajev JG
Neoplasia; 2001; 3(6):480-8. PubMed ID: 11774030
[TBL] [Abstract][Full Text] [Related]
6. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
[TBL] [Abstract][Full Text] [Related]
7. A Transgenic Dual-Luciferase Reporter Mouse for Longitudinal and Functional Monitoring of T Cells
Szyska M; Herda S; Althoff S; Heimann A; Russ J; D'Abundo D; Dang TM; Durieux I; Dörken B; Blankenstein T; Na IK
Cancer Immunol Res; 2018 Jan; 6(1):110-120. PubMed ID: 29259004
[TBL] [Abstract][Full Text] [Related]
8. Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation.
Song Y; Zhu Y; Hu B; Liu Y; Lin D; Jin Z; Yin Z; Dong C; Wu D; Liu H
Front Immunol; 2020; 11():558143. PubMed ID: 33178187
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation.
Tormo A; Khodayarian F; Cui Y; Al-Chami E; Kanjarawi R; Noé B; Wang H; Rafei M
J Hematol Oncol; 2017 Jun; 10(1):120. PubMed ID: 28615039
[TBL] [Abstract][Full Text] [Related]
10. Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.
Vaeth M; Bäuerlein CA; Pusch T; Findeis J; Chopra M; Mottok A; Rosenwald A; Beilhack A; Berberich-Siebelt F
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1125-30. PubMed ID: 25583478
[TBL] [Abstract][Full Text] [Related]
11. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
[TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.
Zakrzewski JL; Kochman AA; Lu SX; Terwey TH; Kim TD; Hubbard VM; Muriglan SJ; Suh D; Smith OM; Grubin J; Patel N; Chow A; Cabrera-Perez J; Radhakrishnan R; Diab A; Perales MA; Rizzuto G; Menet E; Pamer EG; Heller G; Zúñiga-Pflücker JC; Alpdogan O; van den Brink MR
Nat Med; 2006 Sep; 12(9):1039-47. PubMed ID: 16936725
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease.
Kawasaki Y; Sato K; Hayakawa H; Takayama N; Nakano H; Ito R; Mashima K; Oh I; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Fujiwara SI; Ohmine K; Muroi K; Kanda Y
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1563-1574. PubMed ID: 29678638
[TBL] [Abstract][Full Text] [Related]
14. Inducible T-cell receptor expression in precursor T cells for leukemia control.
Hoseini SS; Hapke M; Herbst J; Wedekind D; Baumann R; Heinz N; Schiedlmeier B; Vignali DA; van den Brink MR; Schambach A; Blazar BR; Sauer MG
Leukemia; 2015 Jul; 29(7):1530-42. PubMed ID: 25652739
[TBL] [Abstract][Full Text] [Related]
15. ShcA regulates late stages of T cell development and peripheral CD4+ T cell numbers.
Buckley MW; Trampont PC; Arandjelovic S; Fond AM; Juncadella IJ; Ravichandran KS
J Immunol; 2015 Feb; 194(4):1665-76. PubMed ID: 25595778
[TBL] [Abstract][Full Text] [Related]
16. Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death.
Hartwig UF; Robbers M; Wickenhauser C; Huber C
Blood; 2002 Apr; 99(8):3041-9. PubMed ID: 11929798
[TBL] [Abstract][Full Text] [Related]
17. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
Schneider MK; Grönvik KO
Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
[TBL] [Abstract][Full Text] [Related]
18. Depletion of naïve lymphocytes with fas ligand ex vivo prevents graft-versus-host disease without impairing T cell support of engraftment or graft-versus-tumor activity.
Askenasy N; Mizrahi K; Ash S; Askenasy EM; Yaniv I; Stein J
Biol Blood Marrow Transplant; 2013 Feb; 19(2):185-95. PubMed ID: 23078782
[TBL] [Abstract][Full Text] [Related]
19. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
Lozano T; Villanueva L; Durántez M; Gorraiz M; Ruiz M; Belsúe V; Riezu-Boj JI; Hervás-Stubbs S; Oyarzábal J; Bandukwala H; Lourenço AR; Coffer PJ; Sarobe P; Prieto J; Casares N; Lasarte JJ
J Immunol; 2015 Oct; 195(7):3180-9. PubMed ID: 26324768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
